Top Injectable Manufacturer in Palestine – Reliable Pharmaceutical Solutions
- Maulik Sudani
- 5 hours ago
- 9 min read
Last Updated: August 25, 2026
TL;DR: Palestine is a market defined by two things a supplier has to plan around: a two-sided clearance requirement, and a public procurement channel that only a local partner can enter. Medicines are regulated by the General Directorate of Pharmacy and its Drug Registration Department within the Palestinian Ministry of Health, and the US International Trade Administration records that both Israeli and Palestinian Ministry of Health approvals and registrations are required before pharmaceuticals are shipped into the West Bank and Gaza. The Ministry of Health tenders twice a year and only prequalified Palestinian importers and distributors may bid, so a foreign manufacturer competes through a local partner rather than directly. The high-complexity categories – oncology, HIV, tuberculosis, epilepsy and psychiatry – have long been procured abroad. Farbe Firma Pvt Ltd fills sterile injectables on ISO Class 5 aseptic lines in a WHO-GMP certified facility in Gujarat, India, and builds the dossier, batch and bilingual artwork documentation a Palestinian importer needs to carry a product through both clearances and into a tender.
Key Takeaways
Plan for two regulatory clearances, not one. The US International Trade Administration's commercial guide for the West Bank and Gaza states plainly that Israeli and Palestinian Ministry of Health approvals and registrations are both required before any pharmaceutical, medical device or piece of medical equipment is shipped in. Treat this as an operational fact to be scheduled and documented rather than a formality: it changes lead times, it changes which certificates an importer will ask you for, and it is the single most common reason a first-time exporter's timeline slips. The Palestinian side of that process sits with the Drug Registration Department of the General Directorate of Pharmacy.
Public tenders run through prequalified Palestinian companies, twice a year. The Ministry of Health issues tenders for pharmaceuticals, medical equipment and supplies on a twice-yearly cycle, and only prequalified Palestinian importers and distributors are permitted to bid. A manufacturer outside Palestine therefore does not win a Ministry tender – its local partner does, using the manufacturer's documentation. That makes the quality of what you hand your distributor – certificates of analysis, stability summaries, GMP evidence, bilingual artwork, plant and process documentation – the actual competitive variable.
The specialist and injectable-heavy categories are structurally imported. Palestine has six pharmaceutical factories in the West Bank and local manufacturing is the territory's only domestic medical-products industry, but the published account of the sector records that around 40% of Ministry of Health medicines are procured from Palestinian companies and that complex products for HIV, tuberculosis, oncology, epilepsy and psychiatry are always procured abroad. Those are precisely the therapeutic areas where sterile injectables and cytotoxic handling matter most, and they are where an external manufacturer is filling a structural gap rather than displacing local industry.
Supply continuity is being measured, published and treated as the headline problem. WHO's occupied Palestinian territory situation update covering the period to 31 January 2026 reported 51% of essential medicines at zero stock across the Gaza Strip, including 66% in chemotherapy and blood diseases and 46% in kidney transplantation and haemodialysis. In the West Bank, the Palestinian Ministry of Health stated on 4 June 2026 that 180 of the 520 essential medicines it supplies and 50 of 97 oncology medicines were at zero stock. For a procurement buyer, the practical lesson is that a supplier is judged on whether it can hold a delivery schedule and re-supply against a moving import window.
Introduction: Why Palestine Demands a Premium Injectable Manufacturer in Palestine
Palestine is a small market with unusually demanding logistics, and the suppliers who do well there are the ones who understand that before they quote. Medicines regulation sits with the General Directorate of Pharmacy inside the Palestinian Ministry of Health in Ramallah – a directorate, not a standalone agency – and its Drug Registration Department handles marketing authorisation alongside inspection, import control, licensing, market control, quality control, advertising control, clinical trial control and pharmacovigilance. Importers, wholesalers and distributors are licensed by the Ministry, and manufacturers supplying the market are expected to comply with GMP. The Palestinian Essential Medicine List published for 2024 runs to 653 items across 463 active ingredients, and the Ministry stated in June 2026 that it supplies 520 essential medicines and 97 cancer medicines – the procured subset of that list, and a useful map of where a supplier's portfolio might fit.
What makes the market genuinely different from its neighbours is the import architecture. Under the 1994 Protocol on Economic Relations, Israel and the Palestinian Authority operate within a single customs and tax envelope, with Israel collecting customs and VAT on the Authority's behalf. In practice, as the US International Trade Administration records, that means pharmaceuticals bound for the West Bank and Gaza need approvals and registrations on both the Israeli and the Palestinian side before shipping. None of this is something a foreign manufacturer can shortcut, and none of it is something a Palestinian importer can absorb alone. Choosing an injectable manufacturer in Palestine's supply chain therefore means choosing one whose documentation is complete, current and reissued on request without argument, because that documentation will be presented more than once, to more than one authority, on a timetable nobody fully controls.
What Sets a World-Class Injectable Manufacturer in Palestine Apart
The first differentiator is honesty about what is and is not published. Palestine does not publish a dossier format, a review timeline, a fee schedule or a registration validity period that we can point to, and any supplier who quotes you a confident number for a Palestinian registration timeline is inventing it. What is documented is the shape of the system: products must be registered before marketing; the review considers constituents, manufacturing procedure, quality control procedures, stability studies and clinical information; the Drug Registration Department issues registration certificates as well as Certificates of Pharmaceutical Product and Free Sale Certificates; and medication inserts must be bilingual in Arabic and English. A serious partner tells you that boundary and then prepares a file that would satisfy a strict reviewer in any comparable Eastern Mediterranean market, rather than guessing at a checklist.
The second is fitness for the channel you are actually selling into. Alongside Ministry tenders, a significant volume of medicines reaches Palestinian patients through humanitarian and UN procurement. WHO is the dominant mover of medical supplies into Gaza, reporting more than 923 medical supply trucks since October 2023 including 640 of its own, and UNRWA runs a supplier prequalification process under which only prequalified suppliers may take part in subsequent procurement. UN agency procurement generally runs through WHO Prequalification and assessment against WHO GMP, so a manufacturer whose quality system is already built to that reference has a credible path into the channel. The same manufacturer must also be able to supply in the pack sizes and batch quantities these buyers order, which are rarely the quantities a national tender uses.
Quality Systems Behind Every Sterile Injectable
Farbe Firma fills sterile injectables on ISO Class 5 aseptic lines inside a WHO-GMP certified facility in Gujarat, India. Sterility assurance is designed into the process rather than inferred from a final test: terminal sterilisation or aseptic processing is selected on the product's own merits, supported by media fill validation, routine environmental and personnel monitoring, container closure integrity testing and a documented contamination control strategy. Release testing runs on HPLC and GC for assay and related substances, LAL for bacterial endotoxins, Karl Fischer for water content where the presentation calls for it, and full compendial sterility testing. Every batch ships with a certificate of analysis that a reviewer on either side of the import route can read without a covering explanation.
Stability is generated to ICH Q1A(R2) with photostability under ICH Q1B, in the container-closure system that will actually ship, and defended on hot-climate conditions rather than temperate ones – the right posture for a route that may involve extended port and inland holding times in an Eastern Mediterranean summer. Dossiers are compiled in CTD structure, which is the most portable starting point when a target market has not published a format of its own, and the compendial reference set covers IP, USP, BP and EP. Package inserts and outer artwork are produced bilingually in Arabic and English as the Palestinian Ministry of Health requires, with artwork files supplied in editable form so a local importer can respond to an artwork query without waiting on a new production cycle.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Injectable Manufacturer in Palestine for Global Buyers
The most useful thing a manufacturer can offer a Palestinian buyer right now is predictability, and it is worth being precise about why. The Palestinian Ministry of Health's own June 2026 statement described 180 of 520 essential medicines and 50 of 97 oncology medicines at zero stock in the West Bank, along with 265 specialised medical consumables and 79 laboratory items, and singled out dialysis filters, surgical sutures and cardiac catheterisation supplies. It reported roughly 19,500 surgeries performed in government hospitals between 1 January and 1 June 2026 and more than 11,000 scheduled surgeries postponed. WHO's January 2026 update recorded 18 of Gaza's 36 hospitals partially functional with none fully functional, 3,057 hospital beds including 116 ICU beds, and 641 patients on haemodialysis across four hospitals against a Ministry estimate of up to 1,100 needing it. We cite these figures for one reason: they describe the operating conditions a supplier is being asked to perform in, and they explain why buyers weight schedule reliability and documentation over unit price.
India is already an established origin for medicines reaching Palestine, through both commercial and government channels. UN COMTRADE data reported via Trading Economics puts Palestinian imports of HS Chapter 30 pharmaceutical products from India at about US$7.25 million in 2023, of which roughly US$5.00 million was medicaments in retail packings and US$1.90 million blood fractions, antisera, vaccines and toxins. Separately, the Government of India dispatched humanitarian consignments to Palestine through UNRWA in October 2024 – an initial tranche of around 30 tonnes of medicines and food items on 22 October, followed on 29 October by a further 30 tonnes of medical supplies described as including essential life-saving and anti-cancer drugs. For a Palestinian importer, that means Indian-origin product is neither novel nor unfamiliar to the people who will handle the file.
Farbe Firma Pvt Ltd works as both manufacturer and CDMO, which suits a market where a single product may need to serve a Ministry tender, a private importer and a humanitarian order on three different clocks. We support bilingual Arabic and English artwork and package inserts, flexible batch sizes so a distributor is not forced to buy tender-scale quantities for a private channel, CTD-structured dossier compilation, and the GMP certificates, plant and company profiles, process validation protocols, stability summaries and per-batch certificates of analysis that a prequalified Palestinian importer needs in order to complete a tender submission and clear both sides of the import route. Contract development and manufacturing, own-label supply and technology transfer all run on the same quality system. Because requirements here can change faster than they are published, we also expect buyers to reconfirm current documentation requirements with the General Directorate of Pharmacy before a shipment is committed, and we reissue paperwork to match.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Who regulates medicines and injectables in Palestine?
Regulation sits with the General Directorate of Pharmacy within the Palestinian Ministry of Health in Ramallah, and specifically with its Drug Registration Department. It is a directorate of the Ministry rather than a standalone medicines agency, and its published remit covers marketing authorisation, inspection, import control, licensing of importers, wholesalers and distributors, market control, quality control, control of medicine advertising and promotion, clinical trial control and pharmacovigilance. The same department issues Certificates of Pharmaceutical Product and Free Sale Certificates. Because published procedural detail is limited, importers should confirm current requirements with the Directorate directly rather than relying on secondary summaries.
Does a product need Israeli approval as well as Palestinian approval?
In practice, yes. The US International Trade Administration's commercial guide for the West Bank and Gaza states that Israeli and Palestinian Ministry of Health approvals and registrations are required prior to shipping any pharmaceutical, medical equipment or device into the West Bank and Gaza. This follows from the 1994 Protocol on Economic Relations, under which Israel and the Palestinian Authority operate within a single customs and tax envelope. We state this as an operational fact that affects scheduling and documentation, and we recommend that importers verify the current mechanics on both sides before committing a shipment, since we have not found a published, current description of the Israeli-side process.
How does a foreign manufacturer sell into Palestinian Ministry of Health tenders?
Through a prequalified local partner. The Ministry of Health issues tenders for pharmaceuticals, medical equipment and supplies twice a year, and only prequalified Palestinian importers and distributors are allowed to bid. A manufacturer outside Palestine supports that partner rather than bidding itself, which means the manufacturer's contribution is documentary: GMP evidence, stability data, certificates of analysis, bilingual artwork, plant and process documentation, and a reliable commitment on lead times and pack sizes. Public-sector stock is then distributed through the Ministry's central warehouses to public hospitals and clinics.
What language must labelling and package inserts be in?
Palestinian Ministry of Health requirements are for medication inserts to be bilingual in Arabic and English. Published guidance on design and length is limited, so the practical approach is to prepare artwork that is bilingual, legible at the pack sizes actually used, and supplied in editable source files so that an importer can respond quickly if a reviewer asks for a change. Farbe Firma prepares Arabic and English artwork and inserts as standard for this market.
What makes Farbe Firma a suitable injectable manufacturer for Palestine?
Farbe Firma Pvt Ltd is a WHO-GMP certified sterile injectable manufacturer and CDMO in Gujarat, India, filling on ISO Class 5 aseptic lines and exporting to more than 30 countries. For Palestine specifically we compile CTD-structured dossiers, generate ICH Q1A(R2) and Q1B stability data defended on hot-climate conditions, produce bilingual Arabic and English artwork and inserts, and supply the GMP certificates, process validation protocols, stability summaries and per-batch certificates of analysis a prequalified Palestinian importer needs for a tender file and for clearance. We also work in the smaller batch sizes that private and humanitarian orders use. Contact director@farbefirma.org to discuss a specific molecule, tender or own-label programme.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments